This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Desvenlafaxine
PRISTIQ – Pfizer Canada Inc. (NOC Search)
Patents:
- 2436668: TEVA, APOTEX
APOTEX
- PM(NOC) – A-288-17 (2019 FCA 16) – T-402-16 (2017 FC 774)
TEVA
- PM(NOC) – A-283-17 (2019 FCA 15) – T-1399-15 (2017 FC 777)
Return to the Patented Medicine Litigation page.